This Article Full Text Full Text (PDF) All Versions of this Article: 106/14/1847    most recent 01.CIR.0000031162.80988.2Bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schäfer, K. Articles by Loskutoff, D. J. Search for Related Content PubMed PubMed Citation Articles by Schäfer, K. Articles by Loskutoff, D. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB FERRIC CHLORIDE Related Collections Animal models of human disease Genetically altered mice Physiological and pathological control of gene expression Smooth muscle proliferation and differentiation Arterial thrombosis Coagulation and fibronolysis Other Vascular biology

(Circulation. 2002;106:1847.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator

Katrin Schäfer, MD; Stavros Konstantinides, MD; Carsten Riedel, MD; Therese Thinnes, BS; Katja Müller, MD; Claudia Dellas, MD; Gerd Hasenfuss, MD; David J. Loskutoff, PhD

From Georg August University (K.S., S.K., C.R., K.M., C.D., G.H.), Department of Cardiology and Pulmonary Medicine, Goettingen, Germany, and The Scripps Research Institute (T.T., D.J.L.), Department of Cell Biology, Division of Vascular Biology, La Jolla, Calif.

Correspondence to David J. Loskutoff, PhD, Department of Cell Biology, Division of Vascular Biology, The Scripps Research Institute, 10550 N Torrey Pines Rd, VB-3, La Jolla, CA 92037. E-mail loskutof{at}scripps.edu

Background— Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are thought to play critical roles in vascular remodeling after injury, with tPA mediating intravascular clot lysis and uPA modulating cell migration within the vessel wall. In human vascular disease, however, thrombus organization and neointimal formation are closely interrelated processes. This study examines the differential roles of tPA and uPA in these processes in mice.

Methods and Results— Carotid artery injury and thrombosis were induced in wild-type (WT), uPA-deficient (uPA^-/-), and tPA-deficient (tPA^-/-) mice with the use of ferric chloride. The expression of uPA and tPA was significantly upregulated in the vessel wall of WT mice 1 week after injury, and compared with WT mice, uPA^-/- and tPA^-/- mice had lower carotid patency rates after injury. At 3 weeks, only 55% of uPA^-/- mouse vessels were patent compared with 81% in tPA^-/- mice and 100% in WT mice (P=0.014). Morphometric analysis of injured arterial segments revealed severe luminal stenosis (62±28%) in uPA^-/- mice compared with their tPA^-/- (16±12%) and WT (6.3±3.6%, P<0.001) counterparts. Moreover, although the vascular walls of WT mice and, particularly, tPA^-/- mice developed a cell-rich multilayered neointima and media, the lumen of uPA^-/- vessels remained obstructed with acellular unorganized thrombotic material, and their medial areas did not expand.

Conclusions— These results indicate that the roles of uPA and tPA in the arterial response to injury are different and more complex than previously assumed and emphasize the critical role of thrombus organization and resolution in neointimal formation and vascular pathology.

Key Words: atherosclerosis • carotid arteries • genes • plasminogen activators • thrombosis

This article has been cited by other articles:

				W. P. Fay, N. Garg, and M. Sunkar Vascular Functions of the Plasminogen Activation System Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1231 - 1237. [Abstract] [Full Text] [PDF]

				P. Stoll, N. Bassler, C. E. Hagemeyer, S. U. Eisenhardt, Y. C. Chen, R. Schmidt, M. Schwarz, I. Ahrens, Y. Katagiri, B. Pannen, et al. Targeting Ligand-Induced Binding Sites on GPIIb/IIIa via Single-Chain Antibody Allows Effective Anticoagulation Without Bleeding Time Prolongation Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1206 - 1212. [Abstract] [Full Text] [PDF]

				K. Schafer, M. R. Schroeter, C. Dellas, M. Puls, M. Nitsche, E. Weiss, G. Hasenfuss, and S. V. Konstantinides Plasminogen Activator Inhibitor-1 From Bone Marrow-Derived Cells Suppresses Neointimal Formation After Vascular Injury in Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1254 - 1259. [Abstract] [Full Text] [PDF]

				H. Bujo and Y. Saito Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1246 - 1252. [Abstract] [Full Text] [PDF]

				T. Raupach, K. Schafer, S. Konstantinides, and S. Andreas Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm Eur. Heart J., February 2, 2006; 27(4): 386 - 392. [Abstract] [Full Text] [PDF]

				Y. Li, T. Minamino, O. Tsukamoto, T. Yujiri, Y. Shintani, K.-i. Okada, Y. Nagamachi, M. Fujita, A. Hirata, S. Sanada, et al. Ablation of MEK Kinase 1 Suppresses Intimal Hyperplasia by Impairing Smooth Muscle Cell Migration and Urokinase Plasminogen Activator Expression in a Mouse Blood-Flow Cessation Model Circulation, April 5, 2005; 111(13): 1672 - 1678. [Abstract] [Full Text] [PDF]

				N. Lindenblatt, R. Bordel, W. Schareck, M.D. Menger, and B. Vollmar Vascular Heme Oxygenase-1 Induction Suppresses Microvascular Thrombus Formation In Vivo Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 601 - 606. [Abstract] [Full Text]

				M. Pynn, K. Schafer, S. Konstantinides, and M. Halle Exercise Training Reduces Neointimal Growth and Stabilizes Vascular Lesions Developing After Injury in Apolipoprotein E-Deficient Mice Circulation, January 27, 2004; 109(3): 386 - 392. [Abstract] [Full Text] [PDF]

				K. Schafer, M. Halle, C. Goeschen, C. Dellas, M. Pynn, D. J. Loskutoff, and S. Konstantinides Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 112 - 117. [Abstract] [Full Text] [PDF]

				V. A. Korshunov and B. C. Berk Flow-Induced Vascular Remodeling in the Mouse: A Model for Carotid Intima-Media Thickening Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2185 - 2191. [Abstract] [Full Text] [PDF]

				K. Schafer, K. Muller, A. Hecke, E. Mounier, J. Goebel, D. J. Loskutoff, and S. Konstantinides Enhanced Thrombosis in Atherosclerosis-Prone Mice Is Associated With Increased Arterial Expression of Plasminogen Activator Inhibitor-1 Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2097 - 2103. [Abstract] [Full Text] [PDF]

				T. M. Razzaq, R. Bass, D. J. Vines, F. Werner, S. A. Whawell, and V. Ellis Functional Regulation of Tissue Plasminogen Activator on the Surface of Vascular Smooth Muscle Cells by the Type-II Transmembrane Protein p63 (CKAP4) J. Biol. Chem., October 24, 2003; 278(43): 42679 - 42685. [Abstract] [Full Text] [PDF]

				G. G. Deng, B. Martin-McNulty, D. A. Sukovich, A. Freay, M. Halks-Miller, T. Thinnes, D. J. Loskutoff, P. Carmeliet, W. P. Dole, and Y.-X. Wang Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II-Induced Abdominal Aortic Aneurysm Circ. Res., March 21, 2003; 92(5): 510 - 517. [Abstract] [Full Text] [PDF]

				S. Konstantinides, K. Schafer, and D. J. Loskutoff Do PAI-1 and Vitronectin Promote or Inhibit Neointima Formation?: The Exact Role of the Fibrinolytic System in Vascular Remodeling Remains Uncertain Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1943 - 1945. [Full Text] [PDF]